HK1046362B - 用histacalin蛋白治療結膜炎 - Google Patents

用histacalin蛋白治療結膜炎

Info

Publication number
HK1046362B
HK1046362B HK02107657.7A HK02107657A HK1046362B HK 1046362 B HK1046362 B HK 1046362B HK 02107657 A HK02107657 A HK 02107657A HK 1046362 B HK1046362 B HK 1046362B
Authority
HK
Hong Kong
Prior art keywords
conjunctivitis
treatment
proteins
histacalin
effective
Prior art date
Application number
HK02107657.7A
Other languages
English (en)
Other versions
HK1046362A1 (en
Inventor
Anne Nuttall Patricia
Christiaan Paesen Guido
Original Assignee
Evolutec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evolutec Ltd filed Critical Evolutec Ltd
Publication of HK1046362A1 publication Critical patent/HK1046362A1/xx
Publication of HK1046362B publication Critical patent/HK1046362B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/858—Proteins from animals other than mammals or birds insects; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Polarising Elements (AREA)
  • Surface Treatment Of Glass (AREA)
HK02107657.7A 1999-09-01 2002-10-22 用histacalin蛋白治療結膜炎 HK1046362B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9920674.0A GB9920674D0 (en) 1999-09-01 1999-09-01 Treatment of conjunctivitis
PCT/GB2000/003282 WO2001015719A2 (en) 1999-09-01 2000-08-24 Treatment of conjunctivitis

Publications (2)

Publication Number Publication Date
HK1046362A1 HK1046362A1 (en) 2003-01-10
HK1046362B true HK1046362B (zh) 2005-09-02

Family

ID=10860170

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02107657.7A HK1046362B (zh) 1999-09-01 2002-10-22 用histacalin蛋白治療結膜炎

Country Status (17)

Country Link
US (1) US6737399B2 (zh)
EP (1) EP1207898B1 (zh)
JP (1) JP2003508445A (zh)
CN (1) CN1382057A (zh)
AT (1) ATE289203T1 (zh)
AU (1) AU780773B2 (zh)
BR (1) BR0013665A (zh)
CA (1) CA2382473A1 (zh)
DE (1) DE60018192T2 (zh)
DK (1) DK1207898T3 (zh)
ES (1) ES2235930T3 (zh)
GB (1) GB9920674D0 (zh)
HK (1) HK1046362B (zh)
MX (1) MXPA02001807A (zh)
NZ (1) NZ517218A (zh)
PT (1) PT1207898E (zh)
WO (1) WO2001015719A2 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307544D0 (en) * 2003-04-01 2003-05-07 Evolutec Ltd Treatment method
GB0809279D0 (en) * 2008-05-21 2008-06-25 Varleigh Ltd Histamine binding protein
JP6794454B2 (ja) * 2015-09-25 2020-12-02 オコジェン、インコーポレイテッドＯｋｏｇｅｎ， Ｉｎｃ． ランピルナーゼおよび／またはアンフィナーゼを使用するウイルス性結膜炎の処置
GB201720505D0 (en) * 2017-12-08 2018-01-24 Volution Immuno Pharmaceuticals Sa Methods for treatment of neuropathic pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0906425B1 (en) * 1996-05-18 2005-03-02 Oxford Vacs Ltd. Vasoactive amine binding molecules
CA2309809A1 (en) * 1997-11-26 1999-06-03 Oxford Vacs Ltd. Histamine and serotonin binding molecules

Also Published As

Publication number Publication date
NZ517218A (en) 2004-10-29
DE60018192D1 (de) 2005-03-24
AU6713900A (en) 2001-03-26
DK1207898T3 (da) 2005-06-13
JP2003508445A (ja) 2003-03-04
GB9920674D0 (en) 1999-11-03
EP1207898A2 (en) 2002-05-29
US6737399B2 (en) 2004-05-18
WO2001015719A2 (en) 2001-03-08
HK1046362A1 (en) 2003-01-10
CA2382473A1 (en) 2001-03-08
MXPA02001807A (es) 2003-07-14
WO2001015719A3 (en) 2001-05-10
DE60018192T2 (de) 2005-12-29
US20020151499A1 (en) 2002-10-17
BR0013665A (pt) 2002-05-14
PT1207898E (pt) 2005-05-31
CN1382057A (zh) 2002-11-27
AU780773B2 (en) 2005-04-14
ES2235930T3 (es) 2005-07-16
ATE289203T1 (de) 2005-03-15
EP1207898B1 (en) 2005-02-16

Similar Documents

Publication Publication Date Title
NO995544D0 (no) Forbindelser og metoder for inhibering av ekspresjonen av VCAM-1
ATE279407T1 (de) Fsh mimetika zur behandlung von infertilität
ZA200007753B (en) Benzimidazole analogs as down-regulators of IgE.
YU53899A (sh) Primena inhibitora ciklooksigenaze-2 u prevenciji kardiovaskularnih poremećaja
DE60036968D1 (de) Adamantanderivate zur Behandlung von entzündlichen, immunologischen und kardiovaskulären Erkrankungen
DE69519577T2 (de) Prednisolonmetasulfobenzoat-zusammensetzung zur behandlung von entzündungserkrankung des darmes
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
NO991619L (no) Anvendelse av en H+, K+-ATPase-inhibitor i behandlingen av nesepolypper
HK1046362A1 (en) Treatment of conjunctivitis by histacalin proteins.
TR200102448T2 (tr) COPD tedavisi için kontrollu salma formülasyonu.
NO20010464D0 (no) Fremgangsmåter og sammensetninger for behandling av gastroösofrageal-reflukssyndrom
WO2000040232A3 (en) Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
WO1999057133A3 (en) Inhibitors of nf-kb activation
GB9920673D0 (en) Treatment of allergic rhinitis
DE60122898D1 (de) Aldosteronantagonist und cyclooxygenase-2 hemmer-kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten
ATE409066T1 (de) Einzeldosis aromatase hemmer zur behandlung von unfruchtbarkeit
DE69522940D1 (de) Acylierte enolderivate als vorläufdrogen von elastaseinhibitoren
TR200003084T2 (tr) Paroxetine askorbat
ATE331524T1 (de) Verwendung von lps zur behandlung intestinaler entzündungsprozesse
WO2002072155A3 (de) Verwendung von sydnoniminen zur spezifischen diagnose erektiler dysfunktionen
TNSN00242A1 (en) VALDECOXIB COMPOSITIONS
ITMI961070A0 (it) Prevenzione e trattamento delle infezioni virali topiche con perfluoropolietere o loro composizioni.

Legal Events

Date Code Title Description
CHPA Change of a particular in the register (except of change of ownership)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090824